Agence Nationale de la Recherche (ANR)
In 2022, Domain Therapeutics together with the consortium CONDOR was granted with a multi million financial support from the French National Research Agency (ANR). The consortium led by Institut Bergonié (Pr. Italiano) is dedicated to precision medicine and immunotherapy of sarcoma.
The ANR is dedicated to funding project-based research in France. As a public institution under the authority of the Ministry of Research, the ANR contributes to promote the development of fundamental and targeted research, innovation and technology transfer. It also supports partnerships between research teams from public and private sectors from national to european and international levels. As the main operator of the France 2030 Investment plan, the ANR is a key player in the field of higher education and research. It namely selects, funds and monitors projects involved in actions regarding excellence initiatives, research infrastructures and support for the progress and development of research.